25.45
-0.74%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Beijing Succeeder Technology
Its shares trade on Shanghai under the ticker 688338.SS. It has been listed since 6 August 2020. In the fiscal year to 31 December 2025, it reported revenue of CN¥263.7m and net income of CN¥87.1m. At that date it held total assets of CN¥1.77bn and shareholders' equity of CN¥1.69bn.
Beijing Succeeder Technology, Inc. engages in research, development, production, and sales of detection instruments, reagents, and consumables for thrombosis and hemostasis in the in-vitro diagnosis field. The company is headquartered in Beijing, Beijing. The company went IPO on 2020-08-06. The firm provides medical institutions with automated detection equipment for blood coagulation, blood rheology, hematocrit, platelet aggregation, and supporting reagents and consumables. Its products include testing instruments, reagents and consumables, such as automatic coagulation testers, coagulation quality control kits, Newtonian fluid quality controls, reaction cups and SAW blood rheology special cleaning. The firm operates its businesses within the domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 6 Aug 2020
- Employees
- 273
- Website
- succeeder.com.cn ↗
Leadership
Pay as last reported
- Mr. Shiming WuChairman of the Board, since 2003
- Mr. Guo LiFinance Director, Director
- Mr. Hai WangGeneral Manager, Director
- Ms. Chonghui DingDeputy General Manager, Director, since 2015
- Ms. Tong WuDeputy General Manager, Director
- Mr. Guobin LiuDeputy General Manager
- Mr. Yanbin PeiDeputy General Manager
- Mr. Zhe RenDeputy General Manager
- Mr. Jiahong ZhangSecretary of the Board
- Mr. Xiaofeng GuDirector
- Mr. Zheming JiangIndependent Director
- Ms. Peilin MuIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Beijing Succeeder Technology Inc employs 273 full-time employees in the Health Care sector.
- The company provides automated detection equipment for blood coagulation and hemostasis in China.
- Beijing Succeeder Technology Inc offers reagents and consumables for thrombosis testing in domestic and overseas markets.
Weaknesses
- Beijing Succeeder Technology Inc has no international headquarters beyond Beijing, China.
- The company's business is limited to in-vitro diagnosis field without diversification.
- Beijing Succeeder Technology Inc's IPO date was 6 August 2020, showing limited market history.
Opportunities
- Beijing Succeeder Technology Inc can expand its overseas markets for medical equipment sales.
- The company can develop new products for thrombosis and hemostasis detection in Health Care.
- Beijing Succeeder Technology Inc can leverage its domestic market presence for further growth.
Threats
- Beijing Succeeder Technology Inc faces competition from other Health Care companies in China.
- The company's reliance on in-vitro diagnosis may be affected by regulatory changes.
- Beijing Succeeder Technology Inc's products are limited to blood coagulation and rheology testing.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.